Bionoid Pharma (Bionoid Pharma) EV-to-Revenue : (As of Jun. 01, 2024)

Bionoid Pharma EV-to-Revenue Chart

Bionoid Pharma Quarterly Data
	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11
EV-to-Revenue	Get a 7-Day Free Trial												-	-	-	-	-

Competitive Comparison of Bionoid Pharma's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Bionoid Pharma's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bionoid Pharma's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bionoid Pharma's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Bionoid Pharma's EV-to-Revenue falls into.

Bionoid Pharma EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Bionoid Pharma's EV-to-Revenue for today is calculated as:

Bionoid Pharma's current Enterprise Value is $13.50 Mil.
Bionoid Pharma's Revenue for the trailing twelve months (TTM) ended in Mar. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bionoid Pharma  (OTCPK:BINP) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Bionoid Pharma's PS Ratiofor today is calculated as:

Bionoid Pharma's share price for today is $0.25.
Bionoid Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bionoid Pharma EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Bionoid Pharma's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Bionoid Pharma (Bionoid Pharma) Business Description